Bradykinin B2 receptor activates extracellular signal-regulated protein kinase in mlMCD-3 cells via epidermal growth factor receptor transactivation

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 968-977

  Mukhin, Yurii V ^a   Garnovsky, Evgeny A ^a   Ullian, Michael E ^a   Garnovskaya, Maria N ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ADAPTOR PROTEIN; BRADYKININ; BRADYKININ B2 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GENISTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; PROTEIN SHC; RAS PROTEIN; BRADYKININ RECEPTOR; CALCIUM; CALMODULIN; DNA; GRB2 PROTEIN, MOUSE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN; PROTEIN TYROSINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONCENTRATION RESPONSE; ENZYME ACTIVATION; IMMUNOPRECIPITATION; KIDNEY COLLECTING TUBULE; KIDNEY FUNCTION; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CULTURE MEDIUM; DRUG EFFECT; DRUG INTERACTION; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BRADYKININ; CALCIUM; CALMODULIN; CELLS, CULTURED; CULTURE MEDIA; DNA; DRUG INTERACTIONS; ENZYME ACTIVATION; GRB2 ADAPTOR PROTEIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASE C; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; PROTEINS; RAS PROTEINS; RECEPTOR, BRADYKININ B2; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, BRADYKININ;

EID: 0037332577     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.043943     Document Type: Article

References (40)

1. 2 receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol Cell Biol 19:5289-5297.
2. 2 receptor. Br J Pharmacol 102:962-966.
3. Bernier S, Haldar S, and Michel T (2000) Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem 275:30707-30715.
4. Carpenter G (1999) Employment of the epidermal growth factor receptor in growth factor independent signaling pathways. J Cell Biol 146:697-702.
5. Cobb MH and Goldsmith EJ (1995) How MAP kinases are regulated. J Biol Chem 270:14843-14846.
6. Daub H, Wallasch C, Lankenau A, Herrlich A, and Ullrich A (1997) Signal characteristics of G protein-transactivated EGF receptor. EMBO (Eur Mol Biol Organ) J 16:7032-7044.
7. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, and Lefkowitz RJ (1997) Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. J Biol Chem 272:19125-19132.
8. Dikic I, Tokiwa G, Lev S, Courtneidge SA, and Schlessinger J (1996) A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature (Lond) 383:547-550.
9. Dixon B, Sharma R, Dickerson T, and Fortune J (1994) Bradykinin and angiotensin II: activation of protein kinase C in arterial smooth muscle. Am J Physiol Cell Physiol 266:C1406-C1420.
10. Drube S and Liebmann C (2000) In various tumour cell lines the peptide bradykinin B2 receptor antagonist Hoel40 (Icatibant) may act as mitogenic agonist. Br J Pharmacol 131:1553-1560.
11. Eguchi S, Dempsey PJ, Frank GD, Motley ED, and Inagami T (2001) Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 276:7957-7962.
12. Eguchi S, Iwasaki H, Inagami T, Numaguchi K, Yamakawa T, Motley ED, Owada KM, Marumo F, and Hirata Y (1999) Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension 33:201-206.
13. El-Dahr S, Dipp S, and Baricos WH (1998) Bradykinin stimulates the ERK-Elk-1-Fos/AP-1 pathway in mesangial cells. Am J Physiol Renal Physiol 275:F343-F352.
14. Gao Y, Tang S, Zhou S, and Ware JA (2001) The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J Pharmacol Exp Ther 296:426-433.
15. Goppelt-Struebe M, Fickel S, and Reiser C (2000) The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells. Biochem J 345:217-224.
16. q/11 protein, phosphatidylinositol 3-kinase β and protein kinase Cε. J Biol Chem 273:32016-32022.
17. Graness A, Hanke S, Boehmer FD, Presek P, and Liebmann C (2000) Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transin-activation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells. Biochem J 347:441-447.
18. Grosse R, Roelle S, Herrlich A, Hohn J, and Gudermann T (2000) Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin-releasing hormone. J Biol Chem 275:12251-12260.
19. Gutkind SJ (1998) The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273:1839-1842.
20. Jaffa AA, Miller B, Rosenzweig S, Naidu P, Velarde V, and Mayfield RK (1997) Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells. Am J Physiol Renal Physiol 273:F916-F924.
21. Kalmes A, Vesti BR, Daum G, Abraham JA, and Clowes AW (2000) Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res 87:92-98.
22. Keely SJ, Calandrella SO, and Barrett KE (2000) Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular Ca(2+), PYK-2 and p60(src). J Biol Chem 275:12619-12625.
23. Lal MA, Proulx PR, and Hebert RL (1998) A role for PKC epsilon and MAP kinase in bradykinin-induced arachidonic acid release in rabbit CCD cells. Am J Physiol Renal Physiol 274:F728-F735.
24. Liebmann C (2001) Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell Signal 13:777-785.
25. 2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 275:9572-9580.
26. 2 bradykinin receptor. Proc Natl Acad Sci USA 88:7724-7728.
27. 2 receptor antagonist increases chloride and water absorption in rat medullary collecting duct. Am J Physiol Regul Integr Comp Physiol 271:R352-R360.
28. 2+/calmodulin. J Biol Chem 276:17339 -17346.
29. Naidu PS, Velarde V, Kappler CS, Young RC, Mayfield RK, and Jaffa AA (1999) Calcium-calmodulin mediates bradykinin-induced MAPK phosphorylation and c-fos induction in vascular cells. Am J Physiol Heart Circ Physiol 277:H1061-H1068.
30. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature (Lond) 402:884-888.
31. Rauchman MI, Nigam S, Delpire E, and Gullans SR (1993) An osmotically tolerant inner medullary collecting duct cell line from an SV40 transgenic mouse. Am J Physiol Renal Physiol 265:F416-F424.
32. Seewald S, Schmitz U, Seul C, Ko Y, Sachinidis A, and Vetter H (1999) Lysophosphatidic acid stimulates protein kinase C isoforms alpha, beta, epsilon and zeta in a pertussis toxin sensitive pathway in vascular smooth muscle cells. Am J Hypertens 12:532-537.
33. Tian W, Zhang Z, and Cohen DM (2000) MAPK signaling and the kidney. Am J Physiol Renal Physiol 279:F593-F604.
34. Tomita K, Pisano J, and Knepper MA (1985) Control of sodium and potassium transport in the cortical collecting duct of the rat. J Clin Investig 76:132-136.
35. Tsai W, Morielli AD, and Peralta EG (1997) The M1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO (Eur Mol Biol Organ) J 16:4597-4605.
36. Uchiyama-Tanaka Y, Matsubara H, Nozawa Y, Murasawa S, Mori Y, Kosaki A, Maruyama K, Masaki H, Shibasaki Y, Fujiyama S, et al. (2001) Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int 60:2153-2163.
37. Velarde V, Ullian ME, Morinelli TA, Mayfield RK, and Jaffa AA (1999) Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol Cell Physiol 277:C253-C261.
38. Vio CP, Loyola S, and Velarde V (1992) Localization of components of the kallikreinkinin system in the kidney: relation to renal function. Hypertension 19:II10-II16.
39. Widmann C, Gibson S, Jarpe MB, and Johnson GL (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143-180.
40. Yang XY, Zhang Z, and Cohen DM (1999) ERK activation by urea in the renal inner medullary mIMCD3 cell line. Am J Physiol Renal Physiol 277: F176-F185.